TOLUENE (AMOCO/TOTAL)

MATERIAL SAFETY DATA SHEET



TOLUENE (AMOCO/TOTAL)

MSDS No.  11699000 ANSI/ENGLISH

1.0   CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME:  TOLUENE (AMOCO/TOTAL)

MANUFACTURER/SUPPLIER:

Amoco Chemical Company
200 East Randolph Drive
Chicago, Illinois 60601 U.S.A.


EMERGENCY HEALTH INFORMATION: 
1 (800) 447-8735

EMERGENCY SPILL INFORMATION: 
1 (800) 424-9300 CHEMTREC (USA)

OTHER PRODUCT SAFETY INFORMATION: 
(312) 856-3907

2.0   COMPOSITION/INFORMATION ON INGREDIENTS


Component CAS# Range % by Wt.
Toluene 108-88-3 80
C9 Isoparaffins   9
C8 Isoparaffins   5
Benzene 71-43-2 2
Xylenes   2
Ethylbenzene 100-41-4 2

(See Section 8.0, "Exposure Controls/Personal Protection", for exposure guidelines)


3.0   HAZARDS IDENTIFICATION

EMERGENCY OVERVIEW: Warning! Flammable. Causes eye irritation. Prolonged or repeated contact can defat the skin and lead to irritation and/or dermatitis. Inhalation causes headaches, dizziness, drowsiness, nausea, and respiratory irritation. If swallowed, causes headaches, dizziness, drowsiness and nausea, and may lead to unconsciousness. Harmful or fatal if liquid is aspirated into lungs. Danger! Contains Benzene. Cancer hazard. Can cause blood disorders. Harmful when absorbed through the skin.

POTENTIAL HEALTH EFFECTS: 

EYE CONTACT: Causes mild eye irritation.

SKIN CONTACT: Prolonged or repeated contact can defat the skin and lead to irritation and/or dermatitis. Harmful when absorbed through the skin. Cancer hazard. Can cause blood disorders.

INHALATION: Inhalation causes headaches, dizziness, drowsiness, nausea, and respiratory irritation. See "Toxicological Information" section (Section 11.0).

INGESTION: If swallowed, causes headaches, dizziness, drowsiness and nausea, and may lead to unconsciousness. Harmful or fatal if liquid is aspirated into lungs.

HMIS CODE: (Health:2) (Flammability:3) (Reactivity:0)

NFPA CODE: (Health:2) (Flammability:3) (Reactivity:0)

4.0   FIRST AID MEASURES

EYE: Immediately flush eyes with plenty of water for at least 15 minutes. Then get immediate medical attention.

SKIN: Wash exposed skin with soap and water. Remove contaminated clothing and thoroughly clean and dry before reuse.

INHALATION: If adverse effects occur, remove to uncontaminated area. Give artificial respiration if not breathing. Get immediate medical attention.

INGESTION: If swallowed, drink plenty of water, do NOT induce vomiting. Get immediate medical attention.

5.0   FIRE FIGHTING MEASURES

FLASHPOINT: 40°F(4°C)

UEL: 6.8%

LEL: 1.3%

AUTOIGNITION TEMPERATURE: 997°F (536°C)

FLAMMABILITY CLASSIFICATION: Flammable Liquid.

EXTINGUISHING MEDIA: Agents approved for Class B hazards (e.g., dry chemical, carbon dioxide, foam, steam) or water fog.

UNUSUAL FIRE AND EXPLOSION HAZARDS: Flammable liquid. Vapor may explode if ignited in enclosed area.

FIRE-FIGHTING EQUIPMENT:  Firefighters should wear full bunker gear, including a positive pressure self-contained breathing apparatus.

PRECAUTIONS: Keep away from sources of ignition (e.g., heat and open flames). Use with adequate ventilation. Keep container closed.

HAZARDOUS COMBUSTION PRODUCTS: Incomplete burning can produce carbon monoxide and/or carbon dioxide and other harmful products.

6.0   ACCIDENTAL RELEASE MEASURES

Remove or shut off all sources of ignition. Remove mechanically or contain on an absorbent material such as dry sand or earth. Keep out of sewers and waterways.

7.0   HANDLING AND STORAGE

HANDLING:  Do not breathe vapors. Do not get in eyes. Do not get on skin or clothing.

STORAGE: Store in flammable liquids storage area. Store away from heat, ignition sources, and open flame in accordance with applicable regulations. Keep container closed.

8.0   EXPOSURE CONTROLS / PERSONAL PROTECTION

EYE: Do not get in eyes. Wear chemical goggles.

SKIN: Avoid skin contact. Wear protective clothing and gloves.

INHALATION: Do not breathe mist or vapor. Use with adequate ventilation. If ventilation is inadequate, use NIOSH certified respirator that will protect against organic vapor and dust/mist.

ENGINEERING CONTROLS:  Control airborne concentrations below the exposure guidelines.

EXPOSURE GUIDELINES:

Component CAS# Exposure Limits
Toluene 108-88-3 OSHA PEL: 100 ppm (1989); 200 ppm (1971)
OSHA STEL: 150 ppm (1989); Not established. (1971)
OSHA Ceiling: 300 ppm (1971)
ACGIH TLV-TWA: 50 ppm (skin)
C9 Isoparaffins   No exposure limit established
C8 Isoparaffins   No exposure limit established
Benzene 71-43-2 OSHA PEL: 1 ppm
OSHA STEL: 5 ppm
ACGIH TLV-TWA: 10 ppm
Xylenes   No exposure limit established
Ethylbenzene 100-41-4 OSHA PEL: 100 ppm (1989)(1971)
OSHA STEL: 125 ppm(1989); Not established. (1971)
ACGIH TLV-TWA: 100 ppm
ACGIH TLV-STEL: 125 ppm


9.0   CHEMICAL AND PHYSICAL PROPERTIES

APPEARANCE AND ODOR: Liquid. Clear. Colorless. Aromatic odor.

pH: Not determined.

VAPOR PRESSURE: 26 mm Hg at 25 °C

VAPOR DENSITY: 3.2

BOILING POINT: 231°F(111°C)

MELTING POINT: Not determined.

SOLUBILITY IN WATER: Negligible, below 0.1%.

SPECIFIC GRAVITY (WATER=1): 0.87

EVAPORATION RATE: 

10.0   STABILITY AND REACTIVITY

STABILITY: Burning can be started easily.

CONDITIONS TO AVOID:  Keep away from ignition sources (e.g. heat, sparks, and open flames).

MATERIALS TO AVOID:  None identified.

HAZARDOUS DECOMPOSITION:  Burning can produce carbon monoxide and/or carbon dioxide and other harmful products.

HAZARDOUS POLYMERIZATION:  Will not occur.

11.0   TOXICOLOGICAL INFORMATION

ACUTE TOXICITY DATA: 

EYE IRRITATION: Testing not conducted. See Other Toxicity Data.

SKIN IRRITATION: Testing not conducted. See Other Toxicity Data.

DERMAL LD50: Testing not conducted. See Other Toxicity Data.

ORAL LD50: Testing not conducted. See Other Toxicity Data.

INHALATION LC50: Testing not conducted. See Other Toxicity Data.

OTHER TOXICITY DATA: Specific toxicity tests have not been conducted on this product. Our hazard evaluation is based on information from similar products, the ingredients, technical literature, and/or professional experience.

This stream contains benzene, toluene, xylene and ethylbenzene.

Toluene: Toluene is readily absorbed via inhalation, ingestion, and somewhat through skin contact. In the liquid form, it causes mild skin irritation with a single exposure (PDIS: 4.8/8.0) and dermatitis following repeated exposures. Toluene also produces mild eye irritation (Draise score at 1.0 hour 13.7/110.0) which includes reversible corneal opacity and iritis. It is not a dermal sensitizer. Inhalation in humans has caused mild respiratory irritation (200 ppm), mild eye irritation (400 ppm), and lassitude and slight nausea (600 ppm). Drowsiness occurs at 800 ppm. Very high concentrations may result in paresthesia, dizziness, disturbances of vision, nausea, narcosis, and collapse. It does not induce the hematopoietic effects seen with benzene exposure. Rat oral LD50: 5000 mg/kg; rat inhalation LC50: 4000 ppm (4 hours).

Acute toxicity of benzene results primarily from depression of the central nervous system (CNS). Inhalation of concentrations over 50 ppm can produce headache, lassitude, weariness, dizziness, drowsiness, or excitation. Exposure to very high levels can result in unconsciousness and death.

Long-term overexposure to benzene has been associated with certain types of leukemia in humans. In addition, the International Agency for Research on Cancer (IARC) and OSHA consider benzene to be a human carcinogen. Chronic exposures to benzene at levels of 100 ppm and below have been reported to cause adverse blood effects including anemia. Benzene exposure can occur by inhalation and absorption through the skin.

Inhalation and forced feeding studies of benzene in laboratory animals have produced a carcinogenic response in a variety of organs, including possibly leukemia, other adverse effects on the blood, chromosomal changes and some effects on the immune system. Exposure to benzene at levels up to 300 ppm did not produce birth defects in animal studies; however, exposure to the higher dosage levels (greater than 100 ppm) resulted in a reduction of body weight of the rat pups (fetotoxicity). Changes in the testes have been observed in mice exposed to benzene at 300 ppm, but reproductive performance was not altered in rats exposed to benzene at the same level.

This product contains xylene. Xylene is readily absorbed through the skin. It is also absorbed when inhaled or ingested. Overexposure to xylene can cause eye and respiratory irritation, drowsiness, headache, fatigue, irritability, and gastrointestinal disturbances. Some liver damage and lung inflammation were seen in chronic studies in guinea pigs but not in rats. In rat reproduction studies, xylenes did not produce birth defects but were toxic to the embryo when toxicity to the mother was produced. In a mouse study, xylenes caused birth defects at doses that threatened the life of the mother. The doses which produced these effects were greatly in excess of the TLV. Rat oral LD50: 4300 mg/kg; rat inhalation LC50: 5000 ppm/4 hours.

Aspiration of this product into the lungs can cause chemical pneumonia and can be fatal. Aspiration into the lungs can occur while vomiting after ingestion of this product. Do not siphon by mouth.

12.0   ECOLOGICAL INFORMATION

Ecological testing has not been conducted on this product.

13.0   DISPOSAL INFORMATION

Disposal must be in accordance with applicable federal, state, or local regulations. Residues and spilled material are hazardous waste due to ignitability. Incineration at an EPA-permitted hazardous waste management facility as required by law. Do not landfill.

14.0   TRANSPORTATION INFORMATION

U.S. DEPT OF TRANSPORTATION

Shipping Name Toluene
Hazard Class 3
Identification Number UN1294
Packing Group II
RQ RQ

INTERNATIONAL INFORMATION:

Sea (IMO/IMDG)

Shipping Name Not determined.

Air (ICAO/IATA)

Shipping Name Not determined.

European Road/Rail (ADR/RID)

Shipping Name Not determined.

Canadian Transportation of Dangerous Goods 

Shipping Name Not determined.

15.0   REGULATORY INFORMATION

CERCLA SECTIONS 102a/103 HAZARDOUS SUBSTANCES (40 CFR Part 302.4): This product is reportable under 40 CFR Part 302.4 because it contains the following substance(s):

Component/CAS Number Weight % Component Reportable Quantity (RQ)
Benzene 71-43-2 2 10 lbs.
Ethylbenzene 100-41-4 2 1,000 lbs.
Xylenes 2 100 lbs.
Toluene 108-88-3 80 1,000 lbs.



SARA TITLE III SECTION 302 EXTREMELY HAZARDOUS SUBSTANCES (40 CFR Part 355): This product is not regulated under Section 302 of SARA and 40 CFR Part 355.

SARA TITLE III SECTIONS 311/312 HAZARDOUS CATEGORIZATION (40 CFR Part 370): This product is defined as hazardous by OSHA under 29 CFR Part 1910.1200(d).

SARA TITLE III SECTION 313 (40 CFR Part 372): This product contains the following substance(s), which is on the Toxic Chemicals List in 40 CFR Part 372:

Component/CAS Number Weight Percent
Benzene 71-43-2 2
Ethylbenzene 100-41-4 2
Xylenes 2
Toluene 108-88-3 80


U.S. INVENTORY (TSCA): Listed on inventory.

OSHA HAZARD COMMUNICATION STANDARD: Flammable liquid. CNS Effects.

EC INVENTORY (EINECS/ELINCS):  In compliance.

JAPAN INVENTORY (MITI):  Not determined.

AUSTRALIA INVENTORY (AICS):  Not determined.

KOREA INVENTORY (ECL):  Not determined.

CANADA INVENTORY (DSL):  Not determined.

PHILIPPINE INVENTORY (PICCS):  Not determined.

16.0   OTHER INFORMATION

Prepared by:

  Environment, Health and Safety Department

Issued: April 14, 1997

Supersedes: April 10, 1997


This material Safety Data Sheet conforms to the requirements of ANSI Z400.1.

This material safety data sheet and the information it contains is offered to you in good faith as accurate. We have reviewed any information contained in this data sheet which we received from sources outside our company. We believe that information to be correct but cannot guarantee its accuracy or completeness. Health and safety precautions in this data sheet may not be adequate for all individuals and/or situations. It is the user's obligation to evaluate and use this product safely and to comply with all applicable laws and regulations. No statement made in this data sheet shall be construed as a permission or recommendation for the use of any product in a manner that might infringe existing patents. No warranty is made, either express or implied.